Wilson Mark Andrew

Septerna, Inc. · Chief Legal Officer

Wilson Mark Andrew is listed in filings as Chief Legal Officer at Septerna, Inc.. This profile follows SEC Form 4 activity through Feb 10, 2026, including sale activity. Recent filings connect the profile to Septerna, Inc. (SEPN) and Nektar Therapeutics (NKTR). The current snapshot covers public activity from Aug 20, 2024 to Feb 10, 2026. Reported amounts are shown as $4.2M to $6.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Nektar TherapeuticsNKTR$7.2k5.7k sharesSellAug 19, 2024$1.28$65.40
Nektar TherapeuticsNKTR$6.5k6.4k sharesSellNov 19, 2024$1.01$65.40
Nektar TherapeuticsNKTR$15k16.6k sharesSellDec 24, 2024$0.89$65.40
Nektar TherapeuticsNKTR$30k33.4k sharesSellDec 23, 2024$0.90$65.40
Nektar TherapeuticsNKTR$11k11k sharesSellFeb 19, 2025$1.01$65.40
Nektar TherapeuticsNKTR$6.7k10k sharesSellMay 19, 2025$0.67$65.40
Nektar TherapeuticsNKTR$18k676 sharesSellAug 19, 2025$26.59$65.40
Wilson Mark Andrew History Trades | TradingNote